UW Hospital plans to launch the first study in the country of a cell therapy for a potentially serious complication of kidney transplants, the most common type of organ transplant.

Doctors will infuse donor immune cells into kidney recipients who develop severe infections of cytomegalovirus, or CMV. The virus, generally mild in most people, can become dangerous in patients whose immune systems are suppressed, such as patients who take drugs to prevent rejection of donor organs.